Partial splenic embolization with Glubran2/Lipiodol mixture for oncological patients with hypersplenism-related thrombocytopenia requiring systemic chemotherapy.
Fiche publication
Date publication
mars 2019
Journal
Quantitative imaging in medicine and surgery
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GHIRINGHELLI François, Dr VINCENT Julie, Pr LOFFROY Romaric
Tous les auteurs :
Loffroy R, Falvo N, Nakaï M, Pescatori L, Aho-Gléglé S, Gehin S, Berthod PE, Né R, Vincent J, Ghiringhelli F, Midulla M, Chevallier O
Lien Pubmed
Résumé
Partial splenic embolization (PSE) has been used to improve thrombocytopenia related to hypersplenism. The optimal embolic agent is still debated. The purpose of this study was to evaluate the safety, hematologic response and outcomes of PSE with cyanoacrylate glue for oncological patients with hypersplenism-related thrombocytopenia requiring systemic chemotherapy (SC).
Mots clés
Partial splenic embolization (PSE), cyanoacrylate glue, hypersplenism, systemic chemotherapy, thrombocytopenia
Référence
Quant Imaging Med Surg. 2019 Mar;9(3):409-417